While the world is fighting mRNA jabs, pharma embraces them with open arms—oh, and pockets!

Everyone's a winner!

The gold rush carries on apace

There are so many questions to be answered on the safety, efficiacy, and quality of the Pfizer and Moderna mRNA jabs. Who would blame you for believing that those two companies will be keeping their heads down until the dust clears.

Not a bit of it! Roll up, roll up for the next excursion into fantasy land, and save yourself $1,100 in the process!:

The strapline for the ‘Summit’ goes:

Leveraging non-Coding RNAs to Establish the Next Wave of RNA Therapeutics

So, from vaccines, they move on to therapeutics. They’ll be planning on knocking them up in six or nine months, or quicker if the regulators let them, which they are fixing as we read.

Genetic vaccines were also on the go while the world was fighting C19

Here we have Pfizer, Moderna, little old BioNTech…and AstraZeneca featuring on the front page. This ‘Summit’ was the second to be held during C19: